849067-97-6 Usage
Uses
Used in Pharmaceutical Research and Development:
(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL is used as a building block for the synthesis of biologically active molecules, serving as a key intermediate in the production of potential drug candidates. Its unique structure allows for the development of new medicines and therapeutic agents targeting a variety of diseases and medical conditions.
Used in Drug Discovery:
In the field of drug discovery, (1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL is employed as a starting material for the creation of novel compounds with potential therapeutic effects. Its heterocyclic nature and the presence of both pyrrole and pyridine rings contribute to its versatility in forming diverse chemical entities with potential medicinal properties.
Used in the Development of Therapeutic Agents:
(1H-PYRROLO[2,3-B]PYRIDIN-5-YL)-METHANOL is utilized as a component in the formulation of therapeutic agents, where its chemical properties can be leveraged to address specific medical needs. Its role in this context is to contribute to the overall efficacy and safety of the resulting pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 849067-97-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,0,6 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 849067-97:
(8*8)+(7*4)+(6*9)+(5*0)+(4*6)+(3*7)+(2*9)+(1*7)=216
216 % 10 = 6
So 849067-97-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O/c11-5-6-3-7-1-2-9-8(7)10-4-6/h1-4,11H,5H2,(H,9,10)
849067-97-6Relevant academic research and scientific papers
THERAPEUTIC INHIBITORY COMPOUNDS
-
Page/Page column 175, (2015/07/16)
The invention provides compounds of Formula I and Formula II: A-B-C-D-E-F-G-J (I) C-D-E-F-G-J (II) wherein A, B, C, D, E, F, G, and J have any of the values defined in the specification, and salts thereof. The compounds are useful for inhibiting plasma kallikrein, and for treating a disease or condition in an animal where inhibition of plasma kallikrein is indicated.
HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS
-
Page/Page column 166, (2008/12/05)
Provided herein are Heteroaryl Compounds having the following structure: (I) wherein R1, R2, L, X, Y, Z, Q, A and B are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, metabolic conditions and conditions treatable or preventable by inhibition of a kinase pathway comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.
COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES
-
Page/Page column 142-143; 222, (2010/02/11)
The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
